share_log
Benzinga ·  Feb 13 13:17
Sonnet BioTherapeutics CFO Resigns Effective Feb. 21, 2025; Co Names Donald Griffith As Successor
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
Comment Comment · Views 311

Recommended

Write a comment